Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AM International is a diversified multinational conglomerate headquartered in Singapore, with a significant presence in the global pharmaceutical and healthcare sectors. The company's healthcare operations are primarily managed through its subsidiary, ACIC Pharmaceuticals, which provides a full suite of services including the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. ACIC specializes in complex generics, specialty injectables, and contract manufacturing (CMO/CDMO) for the global market, with a strong focus on North America and Europe. AM International's portfolio also includes interests in petrochemicals and fertilizers, providing a stable industrial foundation for its life sciences division. The group is recognized for its expertise in navigating complex regulatory environments and delivering high-quality, cost-effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AM International.